Please provide your email address to receive an email when new articles are posted on . Aquestive aims to submit a new drug application in the first quarter of 2025. The company hopes to launch in ...
TNX-102 SL is intended to be taken once at bedtime for the management of fibromyalgia. Treatment with TNX-102 SL (cyclobenzaprine HCl sublingual tablets) significantly reduced daily pain in patients ...
A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for epinephrine ...
Please provide your email address to receive an email when new articles are posted on . Researchers called this the first study among children aged 1 to 4 years. The treatment group saw improved ...
For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE ...
Sublingual immunotherapy (SLIT) is as safe and effective for high-risk older children and adolescents as oral immunotherapy (OIT) is for infants and preschoolers, according to new research.
The US Food and Drug Administration (FDA) has approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film for the treatment of opioid dependence, which may increase ...
A new network meta-analysis has compared oral, intramuscular, and sublingual vitamin B12 supplementation, finding intramuscular delivery ranked highest in boosting levels, though differences were not ...
Vitamins are designed to keep our bodies healthy, but sometimes they don’t do their job as well as they should. When we take them orally in tablet or capsule form, the digestive system has to work ...
A consumer-informational overview addressing common search questions about the Quad 4-in-1 compounded sublingual ED ...
VANCOUVER, BC / ACCESSWIRE / December 2, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery ...